BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6152456)

  • 1. Register of multiple endocrine neoplasia type 2 syndromes in the United Kingdom.
    Ponder BA
    Henry Ford Hosp Med J; 1984; 32(4):233-5. PubMed ID: 6152456
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of screening on prognosis in the multiple endocrine neoplasia type 2 syndromes: natural history and treatment results in 105 patients.
    Telenius-Berg M; Berg B; Hamberger B; Tibblin S; Tisell LE; Ysander L; Welander G
    Henry Ford Hosp Med J; 1984; 32(4):225-31. PubMed ID: 6152455
    [No Abstract]   [Full Text] [Related]  

  • 3. [Type II multiple endocrine neoplasia (Sipple syndrome): study of a family].
    Verdy M; Lacroix A; Sturtridge W; Kuchel O; Cadotte M; Schürch W; Cantin J; Cholette JP; Bolté E
    Union Med Can; 1985 Jan; 114(1):49-59. PubMed ID: 2857509
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis, therapy and screening of multiple endocrine neoplasia type I (MEN I) in four endocrinologic centers].
    Schaaf L; Nies G; Raue F; Tuschy U; Seif FJ; Trojan J; Usadel KU
    Med Klin (Munich); 1994 Jan; 89(1):1-6. PubMed ID: 7908402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multiple endocrine neoplasia type 2 A: identification of the gene simplifies screening].
    Telenius H; Mulligan L; Ponder B; Berg B; Berg M; Hallengren B; Jansson S; Svensson KA; Wallin G; Nordenskjöld M
    Lakartidningen; 1994 Mar; 91(13):1307-10, 1315. PubMed ID: 7910223
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinical and genetic investigation of a large kindred with multiple endocrine adenomatosis.
    Johnson GJ; Summerskill WH; Anderson VE; Keating FR
    N Engl J Med; 1967 Dec; 277(26):1379-85. PubMed ID: 4384073
    [No Abstract]   [Full Text] [Related]  

  • 7. Central registration of multiple endocrine neoplasia type 2 families in the Netherlands.
    Lips CJ; den Aantrekker E; Jansen-Schillhorn van Veen JM; Geerdink RA; Griffioen G; van Slooten EA
    Henry Ford Hosp Med J; 1984; 32(4):236-7. PubMed ID: 6152457
    [No Abstract]   [Full Text] [Related]  

  • 8. The molecular genetics of the multiple endocrine neoplasia syndromes.
    Thakker RV
    Clin Endocrinol (Oxf); 1993 Jan; 38(1):1-14. PubMed ID: 8094647
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic testing in multiple endocrine neoplasia and related syndromes.
    Calender A
    Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine neoplasia type 2 syndromes in Japan.
    Takai S; Miyauchi A; Matsumoto H; Ikeuchi T; Miki T; Kuma K; Kumahara Y
    Henry Ford Hosp Med J; 1984; 32(4):246-50. PubMed ID: 6152460
    [No Abstract]   [Full Text] [Related]  

  • 11. Multiple endocrine neoplasia.
    Ponz de Leon M
    Recent Results Cancer Res; 1994; 136():68-83. PubMed ID: 7863108
    [No Abstract]   [Full Text] [Related]  

  • 12. A family pedigree exhibiting features of both multiple endocrine neoplasia type 1 and McCune-Albright syndromes.
    O'Halloran DJ; Shalet SM
    J Clin Endocrinol Metab; 1994 Mar; 78(3):523-5. PubMed ID: 7907339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Genetic detection of multiple endocrine neoplasms type I (Werner syndrome)].
    Giraud-Pinloche S; Chabrier G; Lenoir GM; Calender A
    Presse Med; 1993 Apr; 22(13):637. PubMed ID: 8099736
    [No Abstract]   [Full Text] [Related]  

  • 14. Screening for the multiple endocrine neoplasia syndrome type I. A study of 11 kindreds in The Netherlands.
    Vasen HF; Lamers CB; Lips CJ
    Arch Intern Med; 1989 Dec; 149(12):2717-22. PubMed ID: 2574567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presymptomatic testing using DNA markers for individuals at risk for familial multiple endocrine neoplasia 2A.
    Lichter JB; Wu JS; Genel M; Flynn SD; Pakstis AJ; Kidd JR; Kidd KK
    J Clin Endocrinol Metab; 1992 Feb; 74(2):368-73. PubMed ID: 1346145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of a screening program for multiple endocrine neoplasia type 2A: a clinical study of a Japanese family.
    Shimotake T; Iwai N; Yanagihara J; Kobayashi T; Takai S
    Henry Ford Hosp Med J; 1989; 37(3-4):124-6. PubMed ID: 2576943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multiple endocrine neoplasia. MEN type I].
    Hashizume K; Yamada T
    Nihon Rinsho; 1983 Jun; 41(6):1279-85. PubMed ID: 6137576
    [No Abstract]   [Full Text] [Related]  

  • 18. Multiple endocrine neoplasia type 2A (MEN-2A): natural history, screening, and central registration.
    Brouwers-Smalbraak GJ; Vasen HF; Struyvenberg A; Nieuwenhuijzen Kruseman AC; Helsloot MH; Lips CJ
    Neth J Med; 1986; 29(4):111-7. PubMed ID: 2872602
    [No Abstract]   [Full Text] [Related]  

  • 19. [Multiple endocrine neoplasia. MEN type IIa and type IIb].
    Miyauchi A; Takai S
    Nihon Rinsho; 1983 Jun; 41(6):1286-91. PubMed ID: 6137577
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of screening for the MEN 1 syndrome: diagnostic results and clinical management.
    Lips CJ; Koppeschaar HP; Berends MJ; Jansen-Schillhorn van Veen JM; Struyvenberg A; Van Vroonhoven TJ
    Henry Ford Hosp Med J; 1992; 40(3-4):171-2. PubMed ID: 1362399
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.